Patents by Inventor Markus Muttenthaler

Markus Muttenthaler has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HIGHLY STABLE OXYTOCIN DERIVATIVES
    Publication number: 20260116922
    Abstract: The present invention relates to novel compounds of general formula (I), (I), wherein Z1, X1, R2, R21, n1, W, R3, R31, n2, X2, Rx, R7, R71, R8, Y, n4, n8, R81, n3, X3, Ry, X4, R9, Z9, and m have the meanings given in the description and claims, process for preparing these compounds, and their use as medicaments, specifically for treating, preventing, or ameliorating gastrointestinal disorders.
    Type: Application
    Filed: December 21, 2022
    Publication date: April 30, 2026
    Applicant: UNIVERSITAET WIEN
    Inventors: Thomas KREMSMAYR, Markus MUTTENTHALER
  • Use of single dendritic wedge cell penetrating peptides to facilitate cellular delivery of nanoparticles and nanoparticles carrying cargos
    Patent number: 10183080
    Abstract: Nanoparticles (and optionally a cargo such as a drug) can be delivered to cells by attaching just a single dendritic peptide to the nanoparticle. The dendritic peptide includes a polyhisitidine motif and a hinge and a spacer connecting the polyhistidine to a lysine-based dendritic wedge displaying at least two copies of a cell-penetrating peptide motif.
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: January 22, 2019
    Assignee: The Government of the United States of America, as represented by the Secretary of the Navy
    Inventors: Igor L. Medintz, James B. Delehanty, Joyce Breger, Markus Muttenthaler, Philip E. Dawson
  • Use of Single Dendritic Wedge Cell Penetrating Peptides to Facilitate Cellular Delivery of Nanoparticles and Nanoparticles Carrying Cargos
    Publication number: 20180071399
    Abstract: Nanoparticles (and optionally a cargo such as a drug) can be delivered to cells by attaching just a single dendritic peptide to the nanoparticle. The dendritic peptide includes a polyhisitidine motif and a hinge and a spacer connecting the polyhistidine to a lysine-based dendritic wedge displaying at least two copies of a cell-penetrating peptide motif.
    Type: Application
    Filed: September 1, 2017
    Publication date: March 15, 2018
    Inventors: Igor L. Medintz, James B. Delehanty, Joyce Breger, Markus Muttenthaler, Philip E. Dawson
  • OXYTOCIN PEPTIDE ANALOGUES
    Publication number: 20130130985
    Abstract: Peptide analogues of oxytocin are described together with methods of treating conditions ameliorated by modulating oxytocin receptor. The peptide analogues are seleno or telluro peptide analogues. Methods of synthesis of selenocysteine, tellurocysteine and oxytocin analogues are also described.
    Type: Application
    Filed: May 24, 2010
    Publication date: May 23, 2013
    Inventors: Paul Alewood, Markus Muttenthaler, Zoltan Dekan